市场调查报告书
商品编码
1383333
2030 年化学资讯学市场预测:按产品、应用、最终用户和地区进行的全球分析Cheminformatics Market Forecasts to 2030 - Global Analysis By Product (Services, Software and Other Products), Application, End User and By Geography |
根据Stratistics MRC预测,2023年全球化学资讯学市场规模将达34亿美元,预计2030年将达到105亿美元,预测期内年复合成长率为17.5%。
化学资讯学是解决与化学相关的各种问题的电脑和资讯方法的整合。化学资讯学是各种资讯资源的融合,旨在将资料转化为知识,将知识转化为资讯,以便在先导药物最佳化领域做出更好、更快的决策。製药公司在寻找新药时采用这些技术。这些技术也可以应用于化学和相关领域的各种其他情况。
根据 Frontiers in Chemistry 2021 年 4 月发表的报告,虚拟筛选策略彻底改变了新生物活性分子的发现。
在生技和製药领域,我们不断努力研发尖端药品,开拓市场。化学资讯学软体和技术对于改进药物开发过程的努力至关重要。借助这些工具,研究人员可以快速查询大型资料、模拟分子交互作用并预测潜在候选药物的特性,从而取代通常的试验方法,所涉及的时间和成本可以显着减少。此外,化学资讯学可以帮助化学家发现有趣的候选药物,了解化合物的构效关係,并改善这些分子的特性。因此,化学资讯学市场正在迅速扩大,公司正在利用这些技术来加速药物研发,并最终推出新药和治疗方法来解决各种健康问题。我正在尝试联繫。
实施化学资讯学系统并获得必要的软体、硬体和知识可能非常昂贵,特别是对于资源有限的新兴企业、学术机构和小型研究机构。对于许多潜在用户来说,高级化学资讯学软体的许可成本、购买强大的计算资源以及培训员工有效利用这些工具的成本可能会成为进入障碍。持续的维护、更新和支援成本也增加了财务压力。
毒理学化学资讯学已成为化学资讯学市场的主要驱动力,因为它在确保化学品和药物的安全性和有效性方面发挥着至关重要的作用。由于对严格安全评估和法规遵循的需求不断增加,化学资讯学技术对于预测和评估各种化学品的潜在毒理学效应至关重要。此外,这些技术使科学家能够建模和模拟化学物质如何与生物系统相互作用。该技术在保护公众健康和节省大量时间和资源方面发挥着重要作用。
该领域处理大量敏感的化学和生物资料,包括潜在药物化合物、分子结构和研究结果的详细资讯。尤其是在竞争激烈的化学和製药行业,保护这些资料免于诈欺的存取、洩漏和盗窃是当务之急。然而,法律法规、道德考量以及研究人员遵守严格的资料保护法并解决隐私和智慧财产权问题的需求加剧了这些挑战。资料外洩和不当处理可能会产生严重后果,包括法律后果和声誉损害。
COVID-19大流行对化学资讯学市场产生了各种影响。同时,对快速病毒治疗和疫苗接种的需求推动了化学资讯学技术在药物开发中的使用。研究人员利用这些技术来加速药物开发过程并检查病毒的分子结构及其与潜在治疗分子的相互作用。因此,对化学产品和服务的需求不断增加。然而,大流行给化学资讯学领域带来了挑战。供应链中断、实验室关闭和研究目标的变化影响了该行业的整体运作。
在预测期内,虚拟放映部分将占据最大份额。虚拟筛选是一种计算方法,使用化学资讯学领域的软体和工具来预测和探索治疗分子与特定生物标的(例如蛋白质和酵素)之间的相互作用。这使得科学家能够虚拟评估大型化合物库,减少需要接受额外实验测试的候选治疗药物的数量。透过最大限度地减少必须在实验室中製造和分析的化合物数量,该方法以更少的资金显着加快了药物研发流程。
由于为满足许多领域的研究人员、化学家和科学家的需求而开发的各种专业软体程式和工具,预计软体产业在预测期内将表现出最高的年复合成长率。此外,这些软体程式旨在处理和评估化学和生物资料,协助分子建模,预测化学性质,并加速新药的研发。化学资讯学软体包括虚拟筛选、资料视觉化和分析、化学结构资料库和分子建模工具。
由于生物技术产业资金筹措的增加,北美在预测期内占据了大部分市场。该地区正在加速药物研发、新平台的发布和核准,并且是许多重要公司的所在地。例如,Dotmatics于2022年7月宣布在美国推出小分子药物研发服务。它是一个科学研究和开发的整合平台,具有扩展的资料管理功能和已配置的工作流程。小分子药物研发方案可最大限度地减少业务效率低下,提高研究团队的效率,并加速资料洞察和决策的转变。
由于製造和劳动力成本较低以及有利的工业环境,预计亚太地区在预测期内将出现良好的成长。印度、中国和新加坡等亚太新兴经济体已成功吸引大型跨国企业参与研究。此外,亚太地区快速发展的国家的研究活动的增加预计将进一步支持成长。
According to Stratistics MRC, the Global Cheminformatics Market is accounted for $3.4 billion in 2023 and is expected to reach $10.5 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Chemoinformatics is the integration of computer and informational approaches to a variety of chemistry-related problems. Chemoinformatics is the blending of various information resources with the aim of converting data into knowledge and knowledge into information in order to make better decisions rapidly in the area of drug lead optimization. Pharmaceutical companies employ these methods when seeking for new drugs. These techniques can also be applied in a variety of other contexts in the chemical and related sectors.
According to the report published by Frontiers in Chemistry in April 2021, virtual screening strategies innovated the discovery of new bioactive molecules.
The biotechnology and pharmaceutical sectors constantly strive to develop and market cutting-edge medications. Cheminformatics software and technologies are essential to this endeavor since they haveten the drug development process. With the assistance of these tools, researchers can quickly examine large data sets, model molecular interactions, and forecast the characteristics of possible drug candidates, greatly cutting down on the time and expense normally associated with trial-and-error methods. Additionally, cheminformatics helps chemists discover interesting medication candidates, comprehend the connections between the structure and activity of compounds, and improve the attributes of these molecules. As a result, the market for cheminformatics is expanding rapidly as businesses try to use these technologies to accelerate drug discovery, which will eventually result in the release of new drugs and therapies to deal with a variety of health issues.
Implementing cheminformatics systems along with acquiring the required software, hardware, and knowledge can be expensive, especially for startups, academic institutions, and smaller research organizations with limited resources. For many potential users, the expense of licensing sophisticated cheminformatics software, purchasing potent computational resources, and training employees to utilize these tools effectively might operate as a barrier to entry. Additional ongoing costs for maintenance, updates, and support also add to the financial burden.
Due to the vital role in ensuring the safety and efficacy of chemicals and pharmaceutical substances, chemical informatics for toxicology is a major driver of the cheminformatics market. Cheminformatics technologies are crucial for anticipating and assessing the potential toxicological effects of various chemical substances due to the growing demand for rigorous safety assessments and regulatory compliance. Moreover, with the aid of these technologies, scientists can model and simulate how chemicals interact with biological systems, assisting in the early identification of possible risks and their mitigation. This skill plays a crucial role in safeguarding public health as well as saving a significant amount of time and resources.
Massive amounts of sensitive and confidential chemical and biological data, including details on prospective medicinal compounds, molecular structures, and research findings, are handled within this discipline. A top priority is to protect this data from unauthorized access, breaches, or theft, especially in the fiercely competitive chemical and pharmaceutical industries. However, these difficulties get worse due to legal restrictions, ethical considerations, and the need for researchers to follow strict data protection laws and address privacy and intellectual property issues. Data breaches or improper treatment can have serious repercussions, including legal consequences and reputational harm.
The COVID-19 pandemic has had a wide range of effects on the market for cheminformatics. On the other hand, the need for rapid virus therapies and vaccinations pushed the use of cheminformatics techniques in drug development. These technologies were used by researchers to accelerate the medication development process and examine the molecular structure of the virus and its interactions with prospective therapeutic molecules. The need for chemical products and services increased as a result. The pandemic, however, caused difficulties for the cheminformatics sector. The general operations of the industry were impacted by supply chain disruptions, laboratory closures, and changes in research objectives.
Virtual Screening segment hold the largest share over the projection period. Virtual screening is a method of computing that makes use of software and tools from the field of cheminformatics to forecast and examine the interactions between possible therapeutic molecules and certain biological targets, such as proteins or enzymes. It enables scientists to virtually evaluate a vast library of chemical compounds, reducing the number of potential therapeutic candidates for additional experimental testing. By minimizing the number of compounds that must be manufactured and analyzed in the lab, this method substantially speeds up the drug discovery pipeline while using less capital.
Due to the wide variety of specialized software programs and tools developed to meet the requirements of researchers, chemists, and scientists in many sectors, the software segment is anticipated to have the highest CAGR throughout the projection period. Additionally, these software programs are made to handle and evaluate chemical and biological data, help with molecular modeling, forecast chemical properties, and speed up the creation of new drugs. Cheminformatics software includes tools for virtual screening, data visualization and analysis, chemical structure databases, and molecular modeling.
Due to growing financing in the biotechnology industry, North America held the majority of the market over the predicted period. It accelerates medication discovery, new platform releases and approvals, and the presence of numerous important firms in the area. For instance, Dotmatics introduced its small-molecule drug discovery service in the United States in July 2022. It is an integrated platform for scientific R&D that has expanded data management capabilities and workflows that are already set up. The Small Molecule Drug Discovery Solution minimizes operational inefficiencies, fosters increased research team efficiency, and hastens the conversion of data into insights and decisions.
Asia Pacific is estimated to witness lucrative growth over the forecast period due to low manufacturing and labor costs and a supportive industrial environment, some developing economies in the Asia Pacific area, including India, China, and Singapore, have attracted major multinational firms to conduct research. Additionally, it is anticipated that the increasing rate of research activity in the rapidly developing countries of the Asia-Pacific area will support growth further.
Some of the key players in Cheminformatics market include: Advanced Chemistry Development, Inc., Advent Informatics Pvt. Ltd., Agilent Technologies, Inc., Altoris, Bio-Rad Laboratories, Inc, BioSolveIT GmbH, Cambridgesoft Corp , Certara, Inc., ChemAxon Inc, Collaborative Drug Discovery Inc., Dassault Systems SE, Eidogen-Sertanty, Inc., Golden Helix, Inc., Kode Chemoinformatics, Modgraph Consultants Ltd., Molecular Discovery Ltd, Molinspiration Cheminformatics, Molsoft L.L.C, RTI International, Schrodinger, Inc. and Scilligence Corporation.
In September 2022, Cadence Design Systems, Inc. completed the acquisition of OpenEye Scientific Software, Inc. Adding OpenEye's technologies and experienced team accelerates the Cadence Intelligent System Design strategy. It is done by extending Cadence's computational software core competency to molecular modeling and simulation targeted to life sciences.
In June 2022, TetraScience, the R&D Data Cloud, stated that ChemAxon, one of the leading web-based cheminformatics and bioinformatics software providers, joined the Tetra Partner Network. It is to help customers dramatically increase their capacity to find and synthesize chemical compounds with improved property profiles.